Dr Rachel Hallett

Lecturer in Medical Sciences (Molecular Biology & Biochemistry)

Contact info

Email: r.hallett@bangor.ac.uk

Tel: (01248) 382481

Location: Office 118, Brigantia Building

Contact Info

Email: r.hallett@bangor.ac.uk

Tel: (01248) 382481

Location: Office 118, Brigantia Building

Teaching and Supervision

Course Director for Medical Sciences undergraduate degree (BMedSci Hons).

Module organiser for several modules across the BMedSci programme, and contributor to teaching and supervision on BSc Biomedical Science, MSc Clinical Sciences and Physician Associate programmes.

Personal tutor to undergraduates throughout their three years.

Other roles include Admissions Tutor and Employability Lead for the School of Medical Sciences (SMS), member of the SMS Board of Studies, SMS Staff-Student Liaison Committee, and Healthcare and Medical Sciences Ethics Committee.

Research Activity at Previous HEIs

First position within Public Health England - Colindale, where reference and research work on the blood borne hepatitis viruses led to a PhD in Virology at University College London (UCL).

Postdoctoral position, and later lectureship, at the London School of Hygiene and Tropical Medicine (LSHTM, www.lshtm.ac.uk), studying drug resistance in the malaria parasite Plasmodium falciparum, and contributing to training in malaria endemic countries, and postgraduate teaching programmes in London.

Further postdoctoral position in the coordinating center of a large ovarian cancer screening trial – UKCTOCS (https://www.ucl.ac.uk/womens-health/research/womens-cancer/gynaecological-cancer-research-centre/ukctocs).

https://www.researchgate.net/profile/Rachel_Hallett2

Selected Publications:

Jacobs IJ, Menon U, Ryan A, et al.Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet. 2016 387(10022):945-56.

Henriques G, van Schalkwyk DA, Burrow R, et al The Mu subunit of Plasmodium falciparum clathrin-associated adaptor protein 2 modulates in vitro parasite response to artemisinin and quinine. Antimicrob Agents Chemother. 2015 59(5):2540-7.

Beshir KB, Sutherland CJ, Sawa P, et al. Residual Plasmodium falciparum parasitemia in Kenyan children after artemisinin-combination therapy is associated with increased transmission to mosquitoes and parasite recurrence. J Infect Dis. 2013 208(12):2017-24.

Fairhurst RM, Nayyar GM, Breman JG, et al. Artemisinin-resistant malaria: research challenges, opportunities, and public health implications. Am J Trop Med Hyg. 2012;87(2):231-41.

Timms JF, Menon U, Devetyarov D et al. Early detection of ovarian cancer in samples pre-diagnosis using CA125 and MALDI-MS peaks. Cancer Genomics Proteomics. 2011;8(6):289-305.

Beshir KB, Hallett RL, Eziefula AC et al. Measuring the efficacy of anti-malarial drugs in vivo: quantitative PCR measurement of parasite clearance. Malar J. 2010;9:312.

Beshir K, Sutherland CJ, Merinopoulos I, et al. Amodiaquine resistance in Plasmodium falciparum malaria in Afghanistan is associated with the pfcrt SVMNT allele at codons 72 to 76. Antimicrob Agents Chemother. 2010;54(9):3714-6.

Education / academic qualifications

  • 2012 - Postgraduate Certificate in Learning and Teaching
  • 2001 - PhD , Virology
  • 1995 - BSc , Biology with Industrial Experience (Hons)
View graph of relations